Sarah Jane Tribble
From this contributor
U.S. drug agency moves to guard against abuse of ‘orphan drug’ program
The Food and Drug Administration is changing the way it approves medicines known as 'orphan drugs' after revelations that drugmakers may be abusing a law intended to help patients with rare diseases.
U.S. drug agency moves to guard against abuse of ‘orphan drug’ program
Pharma teams up with rare-disease advocacy groups on Capitol Hill
Critics say vulnerable patients are being manipulated and the goals promoted are skewed by the pharma benefactors who want faster government approval for new products.
Pharma teams up with rare-disease advocacy groups on Capitol Hill
U.S. government plans to probe orphan drug program
Acting on a request from three influential U.S. senators, the government’s accountability arm confirmed that it will investigate potential abuses of the Orphan Drug Act.
U.S. government plans to probe orphan drug program
Senators call for investigation into possible abuses of Orphan Drug Act
Building on weeks of mounting pressure to address high prescription drug prices, three influential U.S. senators have asked the government’s accountability arm to probe the orphan drug program for potential misuse.
Senators call for investigation into possible abuses of Orphan Drug Act
Former head of FDA concerned about faster drug approvals
Robert Califf, the just-departed commissioner of the U.S. Food and Drug Administration, offers his take on the Trump administration's plans to speed up drug approvals and dramatically reduce regulations at the agency.
Former head of FDA concerned about faster drug approvals
Explore more from The Transmitter
Attention not necessary for visual awareness, large study suggests
People can perceive some visual information even if they do not pay direct attention to it.
Attention not necessary for visual awareness, large study suggests
People can perceive some visual information even if they do not pay direct attention to it.
Genetic testing; LSD1 inhibitors; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 30 June.
Genetic testing; LSD1 inhibitors; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 30 June.
INSAR takes ‘intentional break’ from annual summer webinar series
The International Society for Autism Research cited a need to “thoughtfully reimagine” its popular online program before resuming it in 2026.
INSAR takes ‘intentional break’ from annual summer webinar series
The International Society for Autism Research cited a need to “thoughtfully reimagine” its popular online program before resuming it in 2026.